Biological E Ltd
-
{
- All
- News
- Videos
-
Biological E, Bharat Biotech Have 250 Million Covid Vaccine Stockpile: Report
Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received.
-
100 Million Corbevax Doses Supplied To Centre, Says Biological E
Biological E. Ltd (BE) on Thursday said it has delivered 10 crore (100 million) doses of its COVID-19 vaccine, Corbevax, to the Centre so far.
-
Biological E's Corbevax Is Second Covid Vaccine For Children In India
A second COVID-19 vaccine for children has received emergency use authorisation in India. Biological E Ltd's Corbevax has got EUA for children and teens between 12 and 18 years, the vaccine-maker said in a statement today.
-
India's Biological E, US Finalise $50 Million Covid Vaccine Deal: Report
The United States and India's Biological E. Ltd said on Monday they had finalised a financing arrangement for $50 million to expand the vaccine maker's capacity to produce COVID-19 shots.
-
US To Finance India's Biological E In $50 Million Covid Vaccine Deal
The United States and India's Biological E. Ltd said on Monday they had finalised a financing arrangement for $50 million to expand the vaccine maker's capacity to produce COVID-19 shots.
-
Biological E Seeks Regulator's Nod For Phase-3 Trial Of Booster Dose
Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.
-
Can Quickly Adapt To Fight Coronavirus Strains, Say Indian Vaccine Makers
Pharmaceutical companies Bharat Biotech and Biological E Ltd said on Monday they could quickly rework their COVID-19 vaccine products to fight new variants once their genetic sequence is known. In recent months, India has confirmed the presence of the variants first identified in Brazil, Britain and South Africa, which are believed to explain an up...
-
Indian Drugmaker Aims For 60 Crore Johnson & Johnson Vaccine Doses A Year
Pharmaceutical company Biological E Ltd is looking to contract-manufacture roughly 600 million doses of Johnson and Johnson's COVID-19 vaccine candidate annually, Mahima Datla, managing director of the privately-held company said on Wednesday.
-
Hyderabad-Based Firm Biological E Starts Human Trials Of Covid Vaccine Candidate
Biological E. Ltd has started human trials of its COVID-19 vaccine candidate and expects results by February, the drugmaker said on Monday.
-
Biological E, Bharat Biotech Have 250 Million Covid Vaccine Stockpile: Report
Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received.
-
100 Million Corbevax Doses Supplied To Centre, Says Biological E
Biological E. Ltd (BE) on Thursday said it has delivered 10 crore (100 million) doses of its COVID-19 vaccine, Corbevax, to the Centre so far.
-
Biological E's Corbevax Is Second Covid Vaccine For Children In India
A second COVID-19 vaccine for children has received emergency use authorisation in India. Biological E Ltd's Corbevax has got EUA for children and teens between 12 and 18 years, the vaccine-maker said in a statement today.
-
India's Biological E, US Finalise $50 Million Covid Vaccine Deal: Report
The United States and India's Biological E. Ltd said on Monday they had finalised a financing arrangement for $50 million to expand the vaccine maker's capacity to produce COVID-19 shots.
-
US To Finance India's Biological E In $50 Million Covid Vaccine Deal
The United States and India's Biological E. Ltd said on Monday they had finalised a financing arrangement for $50 million to expand the vaccine maker's capacity to produce COVID-19 shots.
-
Biological E Seeks Regulator's Nod For Phase-3 Trial Of Booster Dose
Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.
-
Can Quickly Adapt To Fight Coronavirus Strains, Say Indian Vaccine Makers
Pharmaceutical companies Bharat Biotech and Biological E Ltd said on Monday they could quickly rework their COVID-19 vaccine products to fight new variants once their genetic sequence is known. In recent months, India has confirmed the presence of the variants first identified in Brazil, Britain and South Africa, which are believed to explain an up...
-
Indian Drugmaker Aims For 60 Crore Johnson & Johnson Vaccine Doses A Year
Pharmaceutical company Biological E Ltd is looking to contract-manufacture roughly 600 million doses of Johnson and Johnson's COVID-19 vaccine candidate annually, Mahima Datla, managing director of the privately-held company said on Wednesday.
-
Hyderabad-Based Firm Biological E Starts Human Trials Of Covid Vaccine Candidate
Biological E. Ltd has started human trials of its COVID-19 vaccine candidate and expects results by February, the drugmaker said on Monday.
